Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Diseases × Denosumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13 Neoplasms 4 Neoplasm Metastasis 3 Multiple Myeloma 3 Carcinoma, Renal Cell 3 Smoldering Multiple Myeloma 2 Recurrence 2 Prostatic Neoplasms 2 Osteoporosis 2 Melanoma 2 Kidney Neoplasms 2 Giant Cell Tumor of Bone 2 Bone Cysts, Aneurysmal 2 With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Thyroid Cancer Metastatic 1 Parathyroid Neoplasms 1 Osteoporotic Fractures 1 Osteoblastoma 1 Neoplastic Cells, Circulating 1 Musculoskeletal Pain 1 Mastocytosis, Systemic 1 Lung Neoplasms 1 Inflammatory Breast Neoplasms 1 Hyperparathyroidism, Primary 1 Granuloma, Giant Cell 1 Fractures, Spontaneous 1 Clear-cell metastatic renal cell carcinoma 1 Chondroblastoma 1

Interventions

Letrozole 4 pyrotinib 3 palbociclib 3 Trastuzumab 3 Anastrozole 3 abemaciclib 2 Sodium Chloride 2 Exercise 2 Epirubicin 2 Docetaxel 2 Cyclophosphamide 2 Botulinum Toxins, Type A 2 sacubitril and valsartan sodium hydrate drug combination 1 ribociclib 1 pertuzumab 1 gadoterate meglumine 1 exemestane 1 Vinorelbine 1 Tomography, X-Ray Computed 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgimend 1 Surgical Procedures, Operative 1 Paclitaxel 1 Mammaplasty 1 Liquid Biopsy 1 Leflunomide 1 Lapatinib 1 High-Energy Shock Waves 1 Goserelin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04711109 2025-04-02

BRCA-P

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting

Breast Diseases, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡